RGMB-AS1 Gene

Name RGMB antisense RNA 1
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nLong non‐coding RNA RGMB‑AS1 has emerged as a context‐dependent regulator in diverse cancers. In laryngeal squamous cell carcinoma, gastric cancer, and pancreatic cancer, RGMB‑AS1 is upregulated and contributes to oncogenesis by promoting cell proliferation, invasion, migration, and the epithelial–mesenchymal transition. Mechanistically, it functions as a competing endogenous RNA that sponges microRNAs—miR‑22 in laryngeal squamous cell carcinoma, miR‑22‑3p in gastric cancer, and miR‑574‑3p in pancreatic cancer—to upregulate oncogenic targets such as NLRP3, NFIB, and PIM3, respectively."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "3"}]}, {"type": "t", "text": "\n \nIn contrast, studies in hepatocellular carcinoma and nasopharyngeal carcinoma indicate that RGMB‑AS1 may function as a tumor suppressor. In hepatocellular carcinoma, lower endogenous levels of RGMB‑AS1 are observed, and its forced upregulation suppresses cell proliferation, migration, and invasion while enhancing apoptosis and increasing expression of its sense partner RGMB—correlating with improved patient prognosis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": " Its role is also under exploration in papillary thyroid carcinoma."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": " Furthermore, in nasopharyngeal carcinoma, RGMB‑AS1 inhibits malignant behaviors and the EMT process via direct interaction with FOXA1, suggesting its potential utility as a prognostic indicator."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": "\n \nEmerging evidence in osteosarcoma further underscores the complex and cancer‐type–dependent function of RGMB‑AS1 in tumor progression, highlighting its promise as a novel biomarker and therapeutic target."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Zhenxing Xu, Kai Xi "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA RGMB-AS1 promotes laryngeal squamous cell carcinoma cells progression via sponging miR-22/NLRP3 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2019.109222"}], "href": "https://doi.org/10.1016/j.biopha.2019.109222"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31351424"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31351424"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "W Zhang, F Zhan, D Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "RGMB-AS1/miR-22-3p/NFIB axis contributes to the progression of gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neoplasma (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4149/neo_2020_190418N350"}], "href": "https://doi.org/10.4149/neo_2020_190418N350"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32064882"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32064882"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Wenchong Song, Chengjian Shi "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA RGMB-AS1 facilitates pancreatic cancer cell proliferation and migration but inhibits cell apoptosis via miR-574-3p/PIM3 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Gastrointest Liver Physiol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpgi.00443.2020"}], "href": "https://doi.org/10.1152/ajpgi.00443.2020"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34468207"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34468207"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Nan Sheng, Yannan Li, Ruikun Qian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The clinical significance and biological function of lncRNA RGMB-AS1 in hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2017.12.067"}], "href": "https://doi.org/10.1016/j.biopha.2017.12.067"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29288973"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29288973"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Z Zhang, S-Y Li, L-B Zhang "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA RGMB-AS1 is activated by E2F1 and promotes cell proliferation and invasion in papillary thyroid carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_201804_14725"}], "href": "https://doi.org/10.26355/eurrev_201804_14725"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29687852"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29687852"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Tian Zhang, Ying Jin, Xiangmei Luo "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA RGMB-AS1 represses nasopharyngeal carcinoma progression via binding to forkhead box A1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Bioengineered (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/21655979.2022.2039495"}], "href": "https://doi.org/10.1080/21655979.2022.2039495"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35184697"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35184697"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Peng Yin, Changgui Tong "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA RGMB-AS1 up-regulates ANKRD1 Through Competitively Sponging miR-3614-5p to Promote OSA Cell Proliferation and Invasion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arch Med Res (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.arcmed.2021.08.004"}], "href": "https://doi.org/10.1016/j.arcmed.2021.08.004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34583851"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34583851"}]}]}]}
NCBI Gene ID 503569
API
Download Associations
Predicted Functions View RGMB-AS1's ARCHS4 Predicted Functions.
Co-expressed Genes View RGMB-AS1's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View RGMB-AS1's ARCHS4 Predicted Functions.

Functional Associations

RGMB-AS1 has 834 functional associations with biological entities spanning 3 categories (functional term, phrase or reference, cell line, cell type or tissue, gene, protein or microRNA) extracted from 9 datasets.

Click the + buttons to view associations for RGMB-AS1 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq tissue samples with high or low expression of RGMB-AS1 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset.
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of RGMB-AS1 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of RGMB-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of RGMB-AS1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of RGMB-AS1 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
GTEx Tissue-Specific Aging Signatures tissue samples with high or low expression of RGMB-AS1 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of RGMB-AS1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles cell lines with high or low expression of RGMB-AS1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset.
LOCATE Predicted Protein Localization Annotations cellular components predicted to contain RGMB-AS1 protein from the LOCATE Predicted Protein Localization Annotations dataset.